← back to search

Robert G. Bristow

University of Manchester · GB
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, and Cancer, Hypoxia, and Metabolism.
h-index
98
citations
42,224
works
852
NIH funding
primary concept
email

Recent publications

Tumour hypoxia in driving genomic instability and tumour evolution.
2025cited by 31position: contributordoi
The landscape of N6-methyladenosine in localized primary prostate cancer
Nature Genetics 2025cited by 17position: middledoi
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancer.
2025cited by 14position: contributordoi
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.
2025cited by 9position: contributordoi
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry
Nature Communications 2025cited by 8position: middledoi
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.
2025cited by 3position: contributordoi
Methylation reprogramming associated with aggressive prostate cancer and ancestral disparities
Molecular Systems Biology 2025cited by 2position: middledoi
UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first results.
2025cited by 1position: contributordoi
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer.
2025cited by 1position: contributordoi
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
2025cited by 1position: contributordoi
Clonal evolution and transcriptional plasticity shape metastatic dissemination routes in prostate cancer
Nature Communications 2025cited by 1position: middledoi
Figure 2 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Clonal Evolution and Transcriptional Plasticity Shape Metastatic Dissemination Routes in Prostate Cancer
2025cited by 0position: contributordoi
Supplementary Table 8 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 4 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 3 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 10 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 11 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 1 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 9 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Data from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Figure 3 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 2 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Figure 5 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Figure 6 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 5 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 7 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Figures from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Figure 7 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi
Supplementary Table 6 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 19 papers (2019–2025)Theodorus van der Kwast · Collaborative Group (United States)12 papers (2017–2022)Paul C. Boutros · John Carroll University12 papers (2019–2021)Melvin L.K. Chua · National Cancer Centre Singapore8 papers (2017–2022) · 8 papers (2019–2022)Takafumi N. Yamaguchi · University of Tsukuba7 papers (2019–2021)Mathieu Lupien · UCSF Helen Diller Family Comprehensive Cancer Center7 papers (2019–2025)Ananya Choudhury · JSS Academy of Higher Education and Research6 papers (2021–2025)Alejandro Berlin · Hospital Universitari i Politècnic La Fe6 papers (2019–2022)Julie Livingstone · University of Colorado Denver6 papers (2019–2021)Michael Fraser · Ontario Institute for Cancer Research6 papers (2020–2022) · 5 papers (2017–2021)Silke Gillessen · University Hospitals Seidman Cancer Center5 papers (2019–2022)Paul C. Boutros · University of Virginia5 papers (2017–2021)Mechthild Krause · German Cancer Research Center4 papers (2015–2020)Mark A. Rubin · Praxis4 papers (2020–2022)Vincent Huang · Mount Sinai Hospital4 papers (2019–2021)David C. Wedge · The Christie Hospital4 papers (2022–2025) · 4 papers (2019–2021)Lawrence E. Heisler · Sunnybrook Health Science Centre3 papers (2017–2021)